clinical breakpoints

Working group 3 developed a survey for identifying currently missing veterinary species-specific clinical breakpoints

News
clinical breakpoints, survey
March 10, 2021

Did you know that the antibiogram report on many of the commonly used veterinary drugs are based on pharmacokinetics in people? Or species different from the ones you treat? This lack of species-specific data can negatively impact the reliability of veterinary susceptibility testing and lead to sub-optimal treatment decisions. We would like to invite you to tackle this problem with …

View Post

COST

COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. Our Actions help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation.

COST Action CA18217

The COST Action CA18217 European Network for Optimization of Veterinary Antimicrobial Treatment (ENOVAT) aims to optimize veterinary antimicrobial use with special emphasis on the development of animal- and disease-specific antimicrobial treatment guidelines and refinement of microbiological diagnostic procedures.

Action Details

MoU 034/19: Memorandum of Understanding
CSO Approval date: 04/06/2019
Action duration: 15/11/2019 – 14/11/2023
Participations: More than 250 participants from 45 countries
Email contact: info@enovat.eu

Working group 3 developed a survey for identifying currently missing veterinary species-specific clinical breakpoints

Tag Cloud